Shumyla Jabeen1, Jitender Saini1, Jaladhar Neelavalli2, Narayankrishna Rolla2, Shweta Prasad3, and Ravi Yadav4
1Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India, 2Philips India, Bangalore, India, 3Clinical neurosciences, National Institute of Mental Health and Neurosciences, Bangalore, India, 4Neurology, National Institute of Mental Health and Neurosciences, bangalore, India
Synopsis
Tremor dominant PD and ET often pose a
diagnostic difficulty in view of overlapping clinical features. We aimed at
distinguishing the two using the novel technique of QSM to measure iron
deposition in various gray matter nuclei including the substantia nigra pars
compacta(SNPc). A statistically significant difference was seen in the QSM
values of the SNPc, SNPr and caudate
nucleus. ROC curve analysis showed a sensitivity and specificity of 90 and
87.5% respectively using a cut off value of 12 ppb for the SNPc. Thus, QSM is a
potentially useful problem solving technique for distinguishing tremor dominant
PD from ET.
INTRODUCTION
Parkinson
Disease (PD) and Essential Tremor (ET) are among the most common
neurodegenerative movement disorders affecting the aging population. Tremor is
a cardinal manifestation of both the disease entities. The diagnosis, till
date, is based on clinical criteria. Although ET is characterized by action
tremor and rest tremor is a feature of PD, there can be a significant overlap
in the tremor characteristics leading to a diagnostic dilemma1 . This is especially true
of tremor dominant PD in which tremor is the predominant symptom with minimal
akinesia and rigidity. Also, ET plus syndromes can have other motor and
non-motor manifestations2. Currently, there are no robust imaging
methods to distinguish tremor dominant PD from ET. Recent studies have pointed
to the potential of neuromelanin based contrast in differentiating PD from ET.3 Given the effect that
neuromelanin and tissue iron have on MRI signal in the brain on gradient echo
imaging4 and the
relation between iron deposition and neurodegeneration5, in this study, we evaluated the role of Quantitative
Susceptibility Mapping (QSM) as a possible diagnostic tool to distinguish
tremor dominant PD from ET. QSM evaluates the source magnetic susceptibility of
the tissue that leads to phase contrast and T2* contrast.METHODS
Twenty five (25)
patients of tremor dominant PD and 10 patients of ET were recruited based on
previously described clinical criteria 6-8. After obtaining informed consent, all subjects
underwent MRI in a 3 Tesla Philips Ingenia scanner and multi echo
susceptibility weighted imaging (SWI) data were acquired. Imaging parameters - #echoes=4,
minimum TE=7.2msec, echo spacing=6.2 msec, TR-31 msec, flip angle= 17 degree,
voxel size= 0.6x0.6x2mm, FOV=23 cm. QSM maps were calculated using Meineke et
al’s method9 . Multiecho
SWIp data was utilized for generating the field map which was then used as
input into a regularized de-convolution algorithm for generating the
susceptibility map. Manual ROIs were drawn by a neuroradiologist for bilateral
dentate, red nuclei, substantia nigra pars compacta (SNPc), substantia nigra
pars reticulata (SNPr), globus pallidus interna (GPi), externa (GPe), caudate,
putamina and thalami using Image J as described in a previous study 10(Figure 1). Continuous
variables were expressed as mean with standard deviation. QSM values between
the two groups were compared using the Mann Whitney U test. A p value of
<.05 was regarded as significant. Receiver operating characteristic curve
analysis was performed for the SNPc, SNpr and caudate nucleus. RESULTS
The
mean QSM values in parts per billion (ppb) for the SNPc, SNPr and caudate
nucleus were 33±17, 121±35, 44±14ppb respectively for tremor dominant PD and 8±6,
84±20, 29±10ppb respectively for ET. There was a significant difference in the QSM
values for SNPc, SNPr and caudate nucleus between the two groups with p values
of <.001, .026 and .015 respectively. Figure 2 summarises these findings. ROC curve analysis (Figure 3) revealed area
under the curve of .906, .800 and .774 for the SNPc, caudate and SNPr
respectively. Using cut off values of 12ppb for the SNPc achieved a sensitivity
of 90% and specificity of 85.7% in distinguishing tremor dominant PD from ET.
Sensitivity and specificity of 80 and 57% respectively were seen by setting a
cut off value of 34ppb for the caudate and 72% and 57% respectively for the
SNPr using a cut off value of 92ppb. Representative QSM maps for each group are
shown in Figure 4.DISCUSSION
This
study showed that there is a significant difference in the QSM values of the
SNPc and caudate nucleus between tremor dominant PD and ET. Our findings are
consistent with the basic pathophysiology of PD which involves a loss of
dopaminergic neurons in the substantia nigra pars compacta. The globus pallidus
interna and cerebello-thalamo-cortical loop is proposed to be involved in
essential tremor, although no significant difference was seen on QSM 1.
There is plausible evidence to show that iron deposition may be a primary
phenomena in the causation of PD rather than a secondary neurodegenerative
process 11. Compared to
PD, GABAergic dysfunction is proposed to play a role in the pathophysiology of
ET1. Another significant finding in our study was increased iron
deposition in the caudate nucleus in tremor dominant PD. There is extensive
evidence for the hypothesis that the pacemaker for parkinsonian tremor is
located in the striatum 1,12.
Earlier studies have shown that increased relaxometry values in the basal
ganglia especially the caudate, putamen and thalamus correlate with the tremor
dominant phenotype of PD 13, which is in agreement with our results.
Our study has limitations in the sense that it was a hospital based study with
a small sample size. Studies with a larger sample size are required to further
validate our findings. However, this study has demonstrated the feasibility of
using QSM for future research in this direction.
CONCLUSION
The
results of our study show that QSM could be a useful diagnostic tool for
distinguishing tremor dominant PD from ET. QSM maps can easily be obtained from
multi echo susceptibility weighted sequences without the hassle of contrast
administration, patient preparation, radiation and cost issues related to
molecular imaging. It has the potential to serve as a problem solving tool for
the movement disorder specialist.Acknowledgements
No acknowledgement found.References
1. Helmich RC, Toni I, Deuschl G, Bloem BR. The pathophysiology
of essential tremor and parkinson’s tremor. Current Neurology and Neuroscience
Reports. 2013;13(9).
2. Deuschl G, Bain P, Brin M. Consensus Statement of the
Movement Disorder Society on Tremor. Movement Disorders. 2008 Oct 20;13(S3):2–23.
3. Wang J, Huang Z, Li Y, Ye F, Wang C, Zhang Y, et al.
Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to
differentiate essential tremor from tremor-dominant Parkinson’s disease.
Parkinsonism and Related Disorders. 2019 Jan 1;58:3–8.
4. Lee JH, Baek SY, Song Y, Lim S, Lee H, Nguyen MP, Kim EJ,
Huh GY, Chun SY, Cho H. The Neuromelanin-related T2* Contrast in Postmortem
Human Substantia Nigra with 7T MRI. Sci Rep. 2016 Sep 6;6:32647.
5. Lian TH, Guo P, Zuo LJ, Hu Y, Yu SY, Yu QJ, Jin Z, Wang RD,
Li LX, Zhang W. Tremor-Dominant in Parkinson Disease: The Relevance to Iron
Metabolism and Inflammation. Front Neurosci. 2019 Mar 27;13:255.
6. Marsili L, Rizzo G, Colosimo C. Diagnostic criteria for
Parkinson’s disease: From James Parkinson to the concept of prodromal disease.
Vol. 9, Frontiers in Neurology. Frontiers Media S.A.; 2018.
7. Korchounov A, Schipper HI, Preobrazhenskaya IS, Kessler KR,
Yakhno NN. Differences in age at onset and familial aggregation between clinical
types of Idiopathic Parkinson’s disease. Movement Disorders. 2004
Sep;19(9):1059–64.
8. Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED,
et al. Consensus Statement on the classification of tremors. from the task
force on tremor of the International Parkinson and Movement Disorder Society.
Movement Disorders. 2018 Jan 1;33(1):75–87.
9. Meineke, J., Wenzel,
F., Wilkinson, I. & Katscher, U. No significant increase of magnetic
susceptibility found in subcortical gray matter of patients with Alzheimer’s
Disease. in ISMRM 25th Annual Meeting, Honolulu, HI #2348 (2017).
10. Guan X, Xuan M, Gu Q, Huang P, Liu C, Wang N, et al.
Regionally progressive accumulation of iron in Parkinson’s disease as measured
by quantitative susceptibility mapping. NMR in Biomedicine. 2017 Apr 1;30(4).
11. Brass SD, Chen NK, Mulkern R v., Bakshi R. Magnetic
resonance imaging of iron deposition in neurological disorders. Topics in
Magnetic Resonance Imaging. 2006 Feb;17(1):31–40.
12. Dovzhenok A, Rubchinsky LL.
On the origin of tremor in Parkinson’s disease. PloS one. 2012 Jul
27;7(7):e41598.
13. Bunzeck N, Singh-Curry V, Eckart C, Weiskopf N, Perry RJ,
Bain PG, et al. Motor phenotype and magnetic resonance measures of basal
ganglia iron levels in Parkinson’s disease. Parkinsonism and Related Disorders.
2013 Dec;19(12):1136–42.